Orchestra BioMed Holdings, Inc. (OBIO) Stock: Financials, SEC Filings & Ownership
Orchestra BioMed Holdings, Inc. (OBIO) reported trailing twelve-month revenue of $32.0M (up 986.1% year on year) and net income of -$59.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Market cap: $336.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 336.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 21 days
Price
The price chart — with earnings days, unusual moves, 8-Ks and insider trades marked — opens with a free account.
Our verdict
Five questions and why →Our read on this company
The verdict, the score behind it and the written thesis are in Analyst.
Try it free for 7 daysTiming
Today's price conditions
The verdict, the score behind it and the written thesis are in Analyst.
Try it free for 7 daysAnalyst note
Our written read on this company
The verdict, the score behind it and the written thesis are in Analyst.
Try it free for 7 daysDividends & buybacks
yield — · payout —No dividends or buybacks in the filed statements.
Performance
price return · vs. S&P 500 and the sector| Window | OBIO | vs. S&P 500 | vs. sector |
|---|---|---|---|
| 1 month | -6.0% | -5.1% | -11.6% |
| 3 months | +46.3% | +43.5% | +36.6% |
| 6 months | +35.4% | +28.9% | +11.0% |
| Year to date | +29.7% | +18.5% | +14.4% |
| 1 year | +57.0% | +43.2% | +34.2% |
Orchestra BioMed Holdings, Inc. — questions
- What does Orchestra BioMed Holdings, Inc. do?
- Orchestra BioMed Holdings, Inc. operates in the Medical Instruments & Supplies industry of the Healthcare sector. In its SEC filings it reports 2 business lines: Partnership Revenue (98%), Product (2%). Trailing twelve-month revenue: $32.0 million as of 2026-06-30.
- What is Orchestra BioMed Holdings, Inc.'s revenue?
- $32.0M over the twelve months to 2026-06-30, up 986.1% year on year, from its 10-Q and 10-K filings.
- What is Orchestra BioMed Holdings, Inc.'s market cap?
- $336.0M.
- Who owns Orchestra BioMed Holdings, Inc. stock?
- 77 institutions reported Orchestra BioMed Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Rtw Investments (15.9%), Perceptive Advisors (8.4%), BlackRock (4.2%).
- When does Orchestra BioMed Holdings, Inc. report earnings?
- Orchestra BioMed Holdings, Inc.'s next earnings report is expected on 2026-11-16.
- What sector is Orchestra BioMed Holdings, Inc. in?
- Orchestra BioMed Holdings, Inc. is in the Healthcare sector, Medical Instruments & Supplies industry.
- Who are Orchestra BioMed Holdings, Inc.'s competitors?
- The nearest listed peers by market cap in Medical Instruments & Supplies: AngioDynamics, Inc. (ANGO), DELCATH SYSTEMS, INC. (DCTH), Sight Sciences, Inc. (SGHT), SS Innovations International, Inc. (SSII), SHOULDER INNOVATIONS, INC. (SI).
Every figure on this page comes from Orchestra BioMed Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
Peers and related: AngioDynamics, Inc. (ANGO) · DELCATH SYSTEMS, INC. (DCTH) · Sight Sciences, Inc. (SGHT) · SS Innovations International, Inc. (SSII) · SHOULDER INNOVATIONS, INC. (SI) · All Medical Instruments & Supplies companies
How these figures are read: methodology · EquiReason.